Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacitracin sponge for infection prevention after sinus surgery
NCT01222832Phase 2Completed
- Sponsor
- St. Elizabeth's Medical Center
- Start
- Jul 2010
- Primary completion
- Jun 2012
- Modality
- Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bacitracin in post-operative infection, sponsored by St. Elizabeth's Medical Center. Primary endpoint: Rate of Infection at 90 days. Started Jul 2010; status: completed.
02
Drugs
bacitracin
03
Conditions
post-operative infection
Beyond the preview
Go deeper on NCT01222832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222832.